Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Antifibrotic drugs (nidanib or pirfenidone)
MMF Immunosuppression
Locations
1
Greece
University of patras
Pátrai, Greece
Start Date
June 1, 2025
Primary Completion Date
July 1, 2026
Completion Date
March 1, 2027
Last Updated
March 24, 2026
Lead Sponsor
University of Patras
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions